TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/02/2023
Voltar para busca
Dado oficial do USPTO
SIMBIOSYS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
08/02/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
10/12/2019
Data de registro
31/08/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/08/2021
Última transação
08/02/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
23/07/2020
Primeiro uso no comércio
03/01/2021
Código do desenho
4
Tipo de titular
03
Localização do titular
Champaign, IL, US
Examinador
CHISOLM, KEVON
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SimBioSys, Inc.
Representantes
Bryan G. Helwig McDonnell Boehnen Hulbert & Berghoff LLP
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software for use by physicians for diagnosis and treatment of patients in the field of oncology; downloadable computer software for simulating a patient's predicted tumor response to therapy in the field of oncology; downloadable computer software for visualizing and analyzing a patient's predicted tumor response to therapy in the field of oncology; downloadable computer software for generating reports relating to patient diagnosis and predicted response to therapy in the field of oncology; downloadable computer software for evaluating a patient's disease prognosis and treatment options in the field of oncology; downloadable computer software for displaying medical images in the field of oncology; downloadable computer software for annotating and analyzing medical imaging data in the field of oncology; downloadable computer software for use by physicians for providing precision medicine in the field of oncology; downloadable computer-based tests for precision oncology; downloadable computer software used to support clinical decision making in the field of oncology
Classe 42
Providing temporary use of on-line non-downloadable computer software for use by physicians for diagnosis and treatment of patients in the field of oncology; providing temporary use of on-line non-downloadable computer software for simulating a patient's predicted tumor response to therapy in the field of oncology; computer software for visualizing and analyzing a patient's predicted tumor response to therapy in the field of oncology; providing temporary use of on-line non-downloadable computer software for generating reports relating to patient diagnosis and predicted response to therapy in the field of oncology; providing temporary use of on-line non-downloadable computer software for evaluating a patient's disease prognosis and treatment options in the field of oncology; computer software for displaying medical images in the field of oncology; providing temporary use of on-line non-downloadable computer software for annotating and analyzing medical imaging data in the field of oncology; software for use by physicians for providing precision medicine in the field of oncology; providing temporary use of on-line non-downloadable computer-based tests for precision oncology; providing temporary use of on-line non-downloadable computer software used to support clinical decision making in the field of oncology; research and development in cancer diagnosis and treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
31/08/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
30/07/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
29/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/07/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
30/06/2021
EX2G
SOU EXTENSION 2 GRANTED
30/06/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
30/06/2021
IUAF
USE AMENDMENT FILED
23/06/2021
EXT2
SOU EXTENSION 2 FILED
23/06/2021
EEXT
SOU TEAS EXTENSION RECEIVED
23/06/2021
EISU
TEAS STATEMENT OF USE RECEIVED
23/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/12/2020
EX1G
SOU EXTENSION 1 GRANTED
22/12/2020
EXT1
SOU EXTENSION 1 FILED
22/12/2020
EEXT
SOU TEAS EXTENSION RECEIVED
22/12/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/11/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/11/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
04/11/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/11/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/11/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/11/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/05/2020
PUBO
PUBLISHED FOR OPPOSITION
12/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/04/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
03/04/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
13/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
11/03/2020
ALIE
ASSIGNED TO LIE
11/03/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/03/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
11/03/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/03/2020
DOCK
ASSIGNED TO EXAMINER
10/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/12/2019
NWAP
NEW APPLICATION ENTERED
13/12/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SIMBIOSYS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.